Cargando…

Isorhamnetin Ameliorates Dry Eye Disease via CFTR Activation in Mice

Dry eye disease is one of the most common diseases, with increasing prevalence in many countries, but treatment options are limited. Cystic fibrosis transmembrane conductance regulator (CFTR) is a major ion channel that facilitates fluid secretion in ocular surface epithelium and is a potential targ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ho K., Park, Jinhong, Kim, Bo-Rahm, Jun, Ikhyun, Kim, Tae-im, Namkung, Wan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070004/ https://www.ncbi.nlm.nih.gov/pubmed/33921231 http://dx.doi.org/10.3390/ijms22083954

Ejemplares similares

Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice
por: Jeon, Dongkyu, et al.
Publicado: (2022)

Synthetic Strategies for Improving Solubility: Optimization of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator That Ameliorates Dry Eye Disease
por: Kim, Bo Yi, et al.
Publicado: (2022)

Comparison of Treatment Modalities for Dry Eye in Primary Sjögren’s Syndrome
por: Ahn, Hyunmin, et al.
Publicado: (2022)

Anti-Obesity Effects of Isorhamnetin and Isorhamnetin Conjugates
por: González-Arceo, Maitane, et al.
Publicado: (2022)

Antiplatelet Activity of Isorhamnetin via Mitochondrial Regulation
por: Rodríguez, Lyanne, et al.
Publicado: (2021)

Mechanisms and Effects of Isorhamnetin on Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Wu, Chieh-Shan, et al.
Publicado: (2022)

Potentiation of ΔF508- and G551D-CFTR-Mediated Cl(-) Current by Novel Hydroxypyrazolines
por: Park, Jinhong, et al.
Publicado: (2016)

CFTR-Adenylyl Cyclase I Association Responsible for UTP Activation of CFTR in Well-Differentiated Primary Human Bronchial Cell Cultures
por: Namkung, Wan, et al.
Publicado: (2010)

Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Activation of ADRB2/PKA Signaling Pathway Facilitates Lipid Synthesis in Meibocytes, and Beta-Blocker Glaucoma Drug Impedes PKA-Induced Lipid Synthesis by Inhibiting ADRB2
por: Jun, Ikhyun, et al.
Publicado: (2022)

Fat-lowering effects of isorhamnetin are via NHR-49-dependent pathway in Caenorhabditis elegans
por: Farias-Pereira, Renalison, et al.
Publicado: (2019)

Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial
por: Jun, Ikhyun, et al.
Publicado: (2019)

Regulation of CFTR Bicarbonate Channel Activity by WNK1: Implications for Pancreatitis and CFTR-Related Disorders
por: Kim, Yonjung, et al.
Publicado: (2019)

The mitigative effect of isorhamnetin against type 2 diabetes via gut microbiota regulation in mice
por: Li, Jinjun, et al.
Publicado: (2022)

Conjunctival Fluid Secretion Impairment via CaCC-CFTR Dysfunction Is the Key Mechanism in Environmental Dry Eye
por: Zhang, Jinyu, et al.
Publicado: (2022)

Effects of Isorhamnetin on Adipocyte Mitochondrial Biogenesis and AMPK Activation
por: Lee, Mak-Soon, et al.
Publicado: (2018)

Isorhamnetin-3-O-galactoside Protects against CCl(4)-Induced Hepatic Injury in Mice
por: Kim, Dong-Wook, et al.
Publicado: (2012)

Polygonum cuspidatum stem extract (PSE) ameliorates dry eye disease by inhibiting inflammation and apoptosis
por: Park, Bongkyun, et al.
Publicado: (2019)

Antiviral Effect of Methylated Flavonol Isorhamnetin against Influenza
por: Dayem, Ahmed Abdal, et al.
Publicado: (2015)

Isorhamnetin Has Potential for the Treatment of Escherichia coli-Induced Sepsis
por: Chauhan, Anil Kumar, et al.
Publicado: (2019)

Effect of IRT5 probiotics on dry eye in the experimental dry eye mouse model
por: Moon, Jayoon, et al.
Publicado: (2020)

Dietary component isorhamnetin is a PPARγ antagonist and ameliorates metabolic disorders induced by diet or leptin deficiency
por: Zhang, Yu, et al.
Publicado: (2016)

Isorhamnetin Ameliorates Aspergillus fumigatus Keratitis by Reducing Fungal Load, Inhibiting Pattern-Recognition Receptors and Inflammatory Cytokines
por: Tian, Xue, et al.
Publicado: (2021)

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
por: Sun, Jing, et al.
Publicado: (2013)

New Biodegradable Drug Delivery System for Patients with Dry Eye
por: Park, Beom Chan, et al.
Publicado: (2021)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
por: Gammoh, Omar, et al.
Publicado: (2023)

Pharmacological correction of a defect in PPARγ signaling ameliorates disease severity in Cftr-deficient mice
por: Harmon, Gregory S., et al.
Publicado: (2010)

Isorhamnetin Protects Human Keratinocytes against Ultraviolet B-Induced Cell Damage
por: Han, Xia, et al.
Publicado: (2015)

Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2
por: Seo, Yohan, et al.
Publicado: (2020)

Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1
por: Wang, Manman, et al.
Publicado: (2022)

Pro-Secretory Activity and Pharmacology in Rabbits of an Aminophenyl-1,3,5-Triazine CFTR Activator for Dry Eye Disorders
por: Felix, Christian M., et al.
Publicado: (2017)

Inflammatory Cytokine and Osmolarity Changes in the Tears of Dry Eye Patients Treated with Topical 1% Methylprednisolone
por: Lee, Ji Hwan, et al.
Publicado: (2014)

Genistein‐Calcitriol Mitigates Hyperosmotic Stress‐Induced TonEBP, CFTR Dysfunction, VDR Degradation and Inflammation in Dry Eye Disease
por: Panigrahi, Trailokyanath, et al.
Publicado: (2020)

Ameliorative Potential of Resveratrol in Dry Eye Disease by Restoring Mitochondrial Function
por: Chen, Jingyao, et al.
Publicado: (2022)

Anti-Inflammatory and Anti-Oxidative Effects of Isorhamnetin for Protection Against Lung Injury in a Rat Model of Heatstroke in a Dry-Heat Environment
por: Dong, Xiang, et al.
Publicado: (2022)

Engineering and Evaluation of Forcespun Gelatin Nanofibers as an Isorhamnetin Glycosides Delivery System
por: García-Valderrama, Elsy J., et al.
Publicado: (2022)

Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
por: Alqudah, Abdelrahim, et al.
Publicado: (2023)

Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells
por: Park, Cheol, et al.
Publicado: (2019)

Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics
por: Kim, Tae Kang, et al.
Publicado: (2020)

Inhibition of Aberrant α(1,2)-Fucosylation at Ocular Surface Ameliorates Dry Eye Disease
por: Yoon, Chang Ho, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_psco0pb1gtp5pbl56vobrhv8oe